Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$848M |
| 2 |
Tesla
TSLA
|
+$759M |
| 3 |
Home Depot
HD
|
+$653M |
| 4 |
Meta Platforms (Facebook)
META
|
+$567M |
| 5 |
Wells Fargo
WFC
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$409M |
| 3 |
Micron Technology
MU
|
+$379M |
| 4 |
AT&T
T
|
+$372M |
| 5 |
Medtronic
MDT
|
+$370M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.69% |
| 2 | Technology | 14.95% |
| 3 | Consumer Discretionary | 11.34% |
| 4 | Consumer Staples | 10.7% |
| 5 | Communication Services | 8.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2926
908 Devices
MASS
$329M
| $741K | ﹤0.01% |
+39,000
| New | +$670K |
|
2927
Pliant Therapeutics
PLRX
$64.4M
| $740K | ﹤0.01% |
105,600
+75,293
| +248% | +$768K |
|
|
SY
2928
So-Young International
SY
$185M
| $738K | ﹤0.01% |
372,928
+58,928
| +19% | +$141K |
|
2929
Invesco Water Resources ETF
PHO
$2.01B
| $737K | ﹤0.01% |
13,900
+1,500
| +12% | +$79.5K |
|
2930
GitLab
GTLB
$5.83B
| $735K | ﹤0.01% |
13,500
+10,900
| +419% | +$650K |
|
2931
Abeona Therapeutics
ABEO
$366M
| $733K | ﹤0.01% |
93,033
+5,928
| +7% | +$40.7K |
|
2932
Black Diamond Therapeutics
BDTX
$96.8M
| $733K | ﹤0.01% |
264,491
-120,909
| -31% | -$441K |
|
2933
Praxis Precision Medicines
PRAX
$8.58B
| $733K | ﹤0.01% |
4,787
+3,914
| +448% | +$804K |
|
2934
Vanguard S&P Small-Cap 600 ETF
VIOO
$4.15B
| $733K | ﹤0.01% |
7,400
+3,600
| +95% | +$356K |
|
|
NAPA
2935
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
| $733K | ﹤0.01% |
40,300
+28,700
| +247% | +$560K |
|
2936
Mirum Pharmaceuticals
MIRM
$6.46B
| $731K | ﹤0.01% |
33,200
+4,800
| +17% | +$97.9K |
|
2937
Algoma Steel
ASTL
$406M
| $730K | ﹤0.01% |
+64,900
| New | +$640K |
|
2938
Blue Ridge Bankshares
BRBS
$315M
| $729K | ﹤0.01% |
48,050
+13,650
| +40% | +$228K |
|
|
FBRT
2939
Franklin BSP Realty Trust
FBRT
$630M
| $728K | ﹤0.01% |
+52,100
| New | +$712K |
|
|
NEUE
2940
DELISTED
NeueHealth
NEUE
| $726K | ﹤0.01% |
4,703
-8,392
| -64% | -$1.86M |
|
|
ATSG
2941
DELISTED
Air Transport Services Group
ATSG
| $726K | ﹤0.01% |
+21,700
| New | +$634K |
|
|
MNRL
2942
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
| $726K | ﹤0.01% |
+28,400
| New | +$659K |
|
|
CALB
2943
DELISTED
California BanCorp Common Stock
CALB
| $724K | ﹤0.01% |
31,484
-5,501
| -15% | -$120K |
|
2944
First Guaranty Bancshares
FGBI
$159M
| $723K | ﹤0.01% |
30,183
-15,200
| -33% | -$327K |
|
2945
NextCure
NXTC
$16.8M
| $723K | ﹤0.01% |
12,400
+3,267
| +36% | +$204K |
|
2946
Zevia
ZVIA
$122M
| $723K | ﹤0.01% |
158,297
+76,174
| +93% | +$530K |
|
2947
iShares Micro-Cap ETF
IWC
$1.44B
| $722K | ﹤0.01% |
+5,600
| New | +$719K |
|
2948
Oak Valley Bancorp
OVLY
$285M
| $722K | ﹤0.01% |
39,107
-3,466
| -8% | -$63.7K |
|
2949
Akebia Therapeutics
AKBA
$354M
| $720K | ﹤0.01% |
1,003,327
+380,300
| +61% | +$814K |
|
|
USX
2950
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $720K | ﹤0.01% |
+185,600
| New | +$832K |
|
Similar funds
Renaissance Technologies's Q1 2022 Portfolio in Review
As of Q1 2022, Renaissance Technologies held 4,686 positions worth $85.2B, up 6% from $80.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies deployed $8.98B of net new capital in Q1 2022, opening 822 new positions and adding to 1,556 existing holdings. Its largest new stake was Advanced Micro Devices: 7,107,290 shares worth $777M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Berkshire Hathaway Class A, an estimated $409M trimmed.
- Renaissance Technologies's largest Q1 2022 buy was Advanced Micro Devices: 7,107,290 shares worth $777M.
- Renaissance Technologies added most to Tesla in Q1 2022, an estimated $759M increase.
- Renaissance Technologies's biggest Q1 2022 reduction was Berkshire Hathaway Class A, cutting an estimated $409M.
- Renaissance Technologies fully exited Microsoft in Q1 2022, selling an estimated $786M.
- Renaissance Technologies's ten largest holdings make up 12% of its $85.2B portfolio in Q1 2022.
- Renaissance Technologies opened 822 new positions and closed 650 in Q1 2022.
- Renaissance Technologies's portfolio value rose 6% quarter-over-quarter to $85.2B.
Based on Renaissance Technologies's 13F filing for Q1 2022, filed 13 May 2022.